
Interstitial Lung Disease (ILD) is difficult to diagnose and treat. At first, the disease could look like a variety of other disorders, such as fibrosis or autoimmunity. Once a diagnosis is made, a decision on how aggressively to treat it can mean the difference between irreversible lung damage or overly impacting your patient's quality of life. We caught up with Dr. Robert Hallowell, a Pulmonary and Critical Care physician at the Massachusetts General Hospital and Director of the Interstitial Lung Disease Program at the Pulmonary Ambulatory Clinic. Dr. Hallowell tells us how he evaluates ILD
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Clinical Impact of "Post Approval Pregnancy Safety Studies"

AI Development in Clinical Care: Promises and Pitfalls

Thriving at Every Stage: The Power of Lifestyle Medicine

Dysfunction Mitochondria in Myositis-Driven Inflammation
Free AI-powered recaps of ACR on Air and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.